-+ 0.00%
-+ 0.00%
-+ 0.00%

Plains GP Holdings (PAGP) Stock Can Cash Flow Outrun A $1.26b Loss?

Simply Wall St·08/12/2026 22:34:39
Listen to the news

Plains GP Holdings came into this quarter priced like a steady midstream income stock, with the units almost flat over the past month and barely moving today, up just 0.16% to US$25.15. The market reaction is calm, but the headline is not. In Q2 the company reported a large loss at the earnings per share line, while management emphasized adjusted earnings before interest, tax, depreciation and amortization to reaffirm a full year target of US$2.88b.

Is Plains GP Holdings a rare bargain after reporting such a large quarterly loss, or is the low multiple exactly what this earnings profile deserves? See how the current unit price compares to cash flow assumptions in our valuation analysis for Plains GP Holdings.

Q2 2026 Earnings Summary

  • Revenue Q2 2026 vs. Q2 2025: US$17,693m vs. US$10,642m (up about 66%)
  • Net Income Q2 2026 vs. Q2 2025 (Excluding Extra Items): loss of US$1,260m vs. loss of US$40m (loss widened materially)
  • Basic EPS Q2 2026 vs. Q2 2025: loss of US$6.38 per unit vs. loss of US$0.20 per unit (loss per unit increased sharply)
  • Earnings from Discontinued Operations Q2 2026 vs. Q2 2025: profit of US$1,649m vs. profit of US$70m (large increase in discontinued operations contribution)

Prefer clear visuals instead of another wall of earnings tables and footnotes? See Plains GP Holdings' full financial picture, including a straightforward view of its recent earnings profile and balance sheet strength, in the interactive company report for Plains GP Holdings.

NasdaqGS:PAGP Trailing 12-Month Earnings & Revenue History as at Aug 2026
NasdaqGS:PAGP Trailing 12-Month Earnings & Revenue History as at Aug 2026

Plains GP bullish story leans on cash flow proof

Bulls argue Plains GP Holdings is turning into a steadier, fee heavy cash flow engine, with Permian throughput, Cactus III and deleveraging supporting a more resilient earnings base. The quarter gives some support to that view. Adjusted EBITDA of US$738m sits cleanly within a reaffirmed full year guidance of US$2.88b ± US$75m. This suggests the underlying run rate is tracking management’s plan despite a very large reported EPS loss. Crude segment EBITDA of US$690m shows the core oil pipes and related activities are pulling most of the weight after the NGL sale. Leverage of roughly 3.3x after US$2.9b of debt reduction and projected free cash flow of about US$1.75b for 2026 back up the focus on distributions and balance sheet strength. Raised growth capex tied to producer commitments also lines up with the Permian growth and optimization narrative.

Bear case tests Plains GP earnings quality claims

Bears worry that Plains GP is still highly exposed to crude volumes, regional concentration and asset risk, and that headline EPS volatility signals fragile earnings quality. The widened underlying net income loss of US$1,260m compared with a US$40m loss a year ago, and a sharp loss per unit of US$6.38, underline how far reported profits can diverge from adjusted EBITDA. A very large uplift from discontinued operations at US$1,649m highlights ongoing portfolio churn and the risk of future write downs as assets are re positioned. The need to raise 2026 growth capex to US$400m to US$450m while most of the economic benefit is expected after 2026 also fits concerns that more capital must be deployed just to defend and modestly grow earnings. Management’s own comments about execution timing risk into 2027 show that the path from projects and producer activity to stable unit level results is not yet fully proven.

After these swings in reported earnings, distributions and capital spending, it is fair to ask whether this is the full story or just the surface. Review our independent risk scorecard to expose possible structural weak spots and execution pitfalls in Plains GP Holdings that may not be obvious in headline figures in the risk analysis for Plains GP Holdings which shows 1 important warning sign.

Take Control of Your Next Move

If the mix of adjusted EBITDA, reported losses and one off items around Plains GP Holdings has you watching for a cleaner entry point, register for free with Simply Wall St and add it to a Watchlist to track price against fair value and key financial trends. Once you own it or any other stock, use the Portfolio Command Center to cut through noise and focus on the most important changes to fundamentals, risks and valuation. For a wider view on what other investors are seeing in Plains GP Holdings and similar stocks, tap into the Community to compare different views and questions. By surfacing potential catalysts and risks early, Simply Wall St helps you act with more confidence and stay a step ahead of the market.

Seeking Alternatives Beyond Plains GP Holdings

Fresh ideas can move quickly. Some stocks may be building quiet breakout momentum or dropping into attractive ranges under the radar for now. Do not get caught watching. Consider taking action in line with your strategy.

  • Spot companies with balance sheets that can handle shocks and still fund growth by scanning the curated list of solid balance sheet and fundamentals stocks (49 results). Consider screening before resilience is fully reflected in prices.
  • Explore exposure to long term demand for critical metals by checking the hand picked group of 28 best rare earth metal stocks. Review these opportunities while they may still be less widely followed.
  • Identify potential new income sources by reviewing the focused list of 9 dividend fortresses. Evaluate these options before yields change and entry points move.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.